Ir.omegatherapeutics.com

Omega Therapeutics Unveils New Epigenomic Controller …

WEBOmega Therapeutics, founded by Flagship Pioneering, is a clinical-stage biotechnology company pioneering the first systematic approach to use mRNA therapeutics as a new …

Actived: 2 days ago

URL: https://ir.omegatherapeutics.com/news-releases/news-release-details/omega-therapeutics-unveils-new-epigenomic-controller-development

Omega Therapeutics Announces Appointment of Rainer Boehm to …

WEBOmega Therapeutics, founded by Flagship Pioneering, a clinical-stage biotechnology company pioneering the first systematic approach to use mRNA …

Category:  Health Go Health

Omega Therapeutics Strengthens Team With Key Management …

WEBKevin McManus Appointed as Chief Human Resources Officer. Ling Zeng, Esq., Appointed as Chief Legal and Administrative Officer. CAMBRIDGE, Mass., March …

Category:  Health Go Health

Omega Therapeutics Presents New Preclinical Data Demonstrating …

WEBCoordinated modulation of epigenetic profile of CXCL1-8 genes with corresponding downregulation of gene expression and protein levels, and inhibition of …

Category:  Health Go Health

Omega Therapeutics to Present at the 42nd Annual J.P. Morgan …

WEBCAMBRIDGE, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the …

Category:  Health Go Health

Omega Therapeutics Reports Third Quarter 2023 Financial Results …

WEBAnnounced promising preliminary clinical data for OTX-2002 from ongoing MYCHELANGELO™ I trial; clinical proof-of-platform established with potential …

Category:  Health Go Health

42nd Annual J.P. Morgan Healthcare Conference Omega …

WEB42nd Annual J.P. Morgan Healthcare Conference. Jan 11, 2024 9:45 AM PST. Listen to Webcast.

Category:  Health Go Health

Omega Therapeutics Reports Fourth Quarter and Full Year …

WEBOmega Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update March 1, 2023 Advanced Company s Lead Program, OTX …

Category:  Health Go Health

Omega Therapeutics Reports Third Quarter 2023 Financial …

WEBfrom company employees as well as voting from more than 3,000 life sciences professionals. Third Quarter 2023 Financial Results As of September 30, 2023, the …

Category:  Health Go Health

Omega Therapeutics Announces Appointment of Rainer …

WEBOmega Therapeutics Announces Appointment of Rainer Boehm to its Board of Directors September 1, 2022 Former Novartis Veteran Brings Deep Expertise in Drug …

Category:  Health Go Health

Omega Therapeutics Reports Fourth Quarter and Full Year 2022 …

WEBAdvanced Company’s Lead Program, OTX-2002, in the Clinic; Preliminary Data from Phase 1/2 MYCHELANGELO™ I Trial Anticipated in 2023 Progressed IND …

Category:  Health Go Health

SEC Filing Omega Therapeutics

WEBOn August 3, 2023, Omega Therapeutics, Inc. (the “Company”) entered into an Open Market Sale Agreement SM (the “Sale Agreement”) with Jefferies LLC (“Jefferies”) to …

Category:  Health Go Health

performance or achievements expressed or implied by the …

WEBperformance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: the novel technology

Category:  Health Go Health

SEC Filing Omega Therapeutics

WEBThe Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further …

Category:  Health Go Health

SEC Filing Omega Therapeutics

WEB3. Date of Earliest Transaction (Month/Day/Year) 02/27/2023: 4. If Amendment, Date of Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable Line)

Category:  Health Go Health

ir.omegatherapeutics.com

WEBExplanation of Responses: The shares of Issuer's preferred stock have no expiration date and are convertible at the holder's election into Issuer's common stock at a conversion ra

Category:  Health Go Health

Omega Therapeutics

WEBOmega Therapeutics Announces Research Collaboration with Novo Nordisk to Develop a Novel Therapeutic for Obesity Management Paul.alfano@na… Wed, 01/03/2024 - 13:15

Category:  Health Go Health